The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Re. Regulatory News (FAR)

Share Price Information for Ferro-alloy Re. (FAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
FAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

29 Jun 2022 07:00

RNS Number : 5421Q
Ferro-Alloy Resources Limited
29 June 2022
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

29 June 2022

Ferro-Alloy Resources Limited ('FAR' or the 'Company' or the 'Group')

Grant of Options

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, today announces that is has granted options over 250,000 ordinary shares in the Company ('Options') under the Company's share option scheme to William Callewaert, Chief Financial Officer. 

The Options, which form part of Mr. Callewaert's service agreement dated 23 December 2021 where it was contractually agreed to issue the Options 90 days after Mr. Callewaert's commencement as CFO of the Company (being 1 April 2022), are exercisable on the third anniversary from the date of grant ('Exercise Date') and are exercisable for a period of two years commencing on the Exercise Date. The Options have an exercise price of 13.10p pence being the closing mid-market price of the Company's ordinary shares as quoted on the main market of the London Stock Exchange on the last business day before the date of grant.

Name

Options Granted

Exercise Price

Exercise Date

Total options held post grant

 

William Callewaert

 

250,000

 

13.10p

 

29 June 2025

 

250,000

 

**ENDS**

For further information, visit   www.ferro-alloy.com  or   contact:

 Ferro-Alloy Resources Limited

Nick Bridgen (CEO)

info@ferro-alloy.com

 

Shore Capital

(Joint Corporate Broker)

Toby Gibbs/John More 

+44 207 408 4090

Liberum Capital Limited

(Joint Corporate Broker)

Scott Mathieson/Lydia Zychowska

 

+44 20 3100 2000

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley/Ana Ribeiro

+44 207 236 1177

 

The notification below is made in accordance with the requirements of article 19 of MAR and provides further details, including as to awards granted to persons discharging managerial responsibility, which has been updated accordingly.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

William Callewaert

2.

Reason for the notification

a.

Position/status

Finance Director

b.

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Ferro Alloy Resources Limited

b.

LEI

213800WAVVOPS85N2205

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument Identification code

Ordinary Shares NPV

GG00BGDYDZ69

b.

Nature of the transaction

Grant of Share Options

c.

Price(s) and volume(s)

 

Price

Volume

13.35p

 

250,000

d.

Aggregated information

- Aggregated volume

- Price

 

250,000

13.10 pence

e.

Date of the transactions

29 June 2022

f.

Place of the transactions

London Stock Exchange

 

 

 

About Ferro Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")  

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.  

A reserve on the JORC 2012 basis has been estimated only for the first ore-body (of five) which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5.  

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat concentrates and expanded. Further expansion is being undertaken which is expected to result in annualised production capacity of around 1,500 tonnes of contained vanadium pentoxide plus significant by-product molybdenum.  

The strategy of the Company is to develop both the Project and the Existing Operation in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSELFWAEESESM
Date   Source Headline
19th Mar 20214:35 pmRNSPrice Monitoring Extension
19th Mar 20212:05 pmRNSSecond Price Monitoring Extn
19th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202112:00 pmRNSIssue of Equity
17th Mar 20219:05 amRNSSecond Price Monitoring Extn
17th Mar 20219:00 amRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 202112:45 pmRNSDirector Share Purchase
16th Mar 202111:05 amRNSSecond Price Monitoring Extn
16th Mar 202111:00 amRNSPrice Monitoring Extension
16th Mar 20219:06 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
15th Mar 20219:05 amRNSSecond Price Monitoring Extn
15th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 20217:01 amRNSStrategic Investment & Appointment of Chairman
15th Mar 20217:00 amRNS2020 Production & Operations Update Issue of Bonds
11th Jan 20217:00 amRNSIssue of Bonds
11th Nov 20207:00 amRNSIssue of Bonds
2nd Nov 20207:00 amRNSResult of AGM
26th Oct 20207:00 amRNSCommercial Production & Sales of Calcium Molybdate
22nd Oct 202011:15 amRNSHolding(s) in Company
20th Oct 20209:05 amRNSSecond Price Monitoring Extn
20th Oct 20209:00 amRNSPrice Monitoring Extension
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202011:06 amRNSSecond Price Monitoring Extn
19th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20207:00 amRNSProduction and Progress Update
2nd Oct 20207:00 amRNSNotice of AGM
30th Sep 20207:00 amRNSInterim Results
16th Sep 20207:00 amRNSFinancing and Operational Enhancement
3rd Sep 20207:00 amRNSShare Subscription
2nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20204:35 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSElectrolyte for Vanadium Flow Batteries & AIX Bond
30th Jun 20207:00 amRNSIssue of Equity to Directors
29th Jun 20207:00 amRNSFinal Results
12th Jun 20207:00 amRNSOperational and Financing Update
2nd Jun 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20202:05 pmRNSSecond Price Monitoring Extn
2nd Jun 20202:00 pmRNSPrice Monitoring Extension
14th May 202011:34 amRNSIssue of Equity
1st May 20207:00 amRNSFull Year Results Deferral and Ops Update
3rd Apr 20207:00 amRNSIssue of Ordinary Shares & Total Voting Rights
19th Mar 20207:00 amRNSDirector Lock-In & Orderly Marketing Arrangement
21st Feb 20204:18 pmRNSConfirmation of cancellation of listing from KASE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.